ArticleBMC veterinary research2026
Development and partial validation of a TaqMan quantitative PCR assay to detect Cervidpoxvirus.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn emerging disease known as mule deerpox virus (Cervidpoxvirus muledeerpox) (DPV) has spread across North America in both wild and captive cervid populations. While little is known about its prevalence in wild cervids, research in domestic populations indicates a high mortality associated with this pathogen, particularly in fawns. Most recently, a new Cervidpoxvirus has been reported in semi-domestic populations of reindeer in Sweden and Norway, expanding its geographical range internationally. Currently, there is no standard protocol to detect this virus, and the increasing range of this pathogen highlights the importance of a standard validated diagnostic test.
resultsIn this study, we developed and partially-validated a TaqMan quantitative PCR assay to detect Cervidpoxvirus based on the major capsid protein using the World Organization for Animal Health's diagnostic assay guidelines. Aligning the three available whole genomes of DPV from GenBank W-848-83 (GenBank: NC_006966.1); W-1170-84 (GenBank: AY689437.1); MDPV-F (GenBank: MF966153), showed that the major capsid protein gene was highly conserved (> 99%) and primers and probe were designed to amplify a 83 bp region of this gene with 100% agreement. Analytical performance estimated that the assay was exclusive for DPV and highly sensitive (limit of detection ≥ 10 DNA copies), while diagnostic performance found that the assay was 100 times more sensitive than a standard conventional PCR assay.
conclusionWith this assay, detection of Cervidpoxvirus will be faster and more efficient than current methods, allowing both researchers and veterinarians to diagnose and prevent the further spread of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.